Industry News
$42.5m neuroscience facility opens
Brain and mind disorders, watch out -- Australia's neuroscience researchers are coming after you. [ + ]
Neuro facility teams with UK firm to develop MND model
A commercial alliance has been formed between the National Neuroscience Facility (NNF) and UK company Danio Labs, to develop a zebrafish model for Motor Neurone Disease (MND) and other neurodegenerative diseases. [ + ]
New transgene delivery technique takes a traditional route
An Italian-Australian research partnership has demonstrated a potentially revolutionary technique for producing transgenic animals, using nature's own time-tested vector for delivering genes to eggs: sperm. [ + ]
Eiffel to collaborate with UK asthma company
Melbourne biotech Eiffel Technologies has signed an agreement with a UK-based drug delivery company, Meridica, to reengineer asthma therapeutics for use in a new technology inhalation device. [ + ]
Evogenix teams with UK firm Domantis
EvoGenix has signed an agreement with UK-based Domantis to apply its protein evolution and optimisation technology to one of Domantis's domain antibody therapeutic leads. [ + ]
From eucalypt survival to Wollemi Pine decline
The Charles Sturt University (CSU) botanist who discovered the secret bushfire survival skills of the eucalypt has turned his attention to a suspected 'design flaw' in the endangered Wollemi Pine.
[ + ]Sugar industry sweetened by biotech research centre
The Australian sugar industry will receive a huge boost when the $54 million Cooperative Research Centre (CRC) for Sugar Industry Innovation through Biotechnology opens for business in Queensland this month.
[ + ]West Nile lookalike gives vaccine hope
Researchers at the University of Queensland have developed a clone of the locally endemic Kunjin virus, and successfully trialled in mice it as a West Nile virus (WNV) vaccine. [ + ]
Polartechnics ramps up for Italian job
Device maker Polartechnics is to focus on the Italian market for the introduction of its TruScreen cervical cancer diagnostic device, as a precursor to a major push into the European screening arena. [ + ]
National Neuroscience Facility opens for business
Cooperative competition -- or 'coopetition' -- was the name of the game last night at the launch of the AUD$18 million National Neuroscience Facility in Melbourne. [ + ]
Former BioComm VP moves to Select
Dr Anthony Filippis, formerly of BioComm, has joined recently listed Select Vaccines as VP of business development. [ + ]
Former Coles CEO joins Starpharma board
Starpharma has appointed prominent Melbourne businessman Peter Bartels as a director and chairman of its board of directors, replacing Richard Oliver, who has retired. [ + ]
CSIRO licenses bio-bone
CSIRO has formed a strategic alliance with UK-based medical device company AorTech producing spinal disc implants, using a unique polymer developed by Melbourne researchers. [ + ]
Prima, Prana to team on Alzheimer's vaccine
Melbourne biotechs Prima BioMed and Prana Biotechnology will collaborate on a project to develop a vaccine for Alzheimer's disease, the companies announced today. [ + ]
Expat to lead UK firms to AusBiotech conference
Delegates from 10 UK biotechnology companies will attend the upcoming AusBiotech 2003 conference in Adelaide, led by expatriate Australian Dr John Sime, currently the director of research support and development at Imperial College, London. [ + ]
